Calingasan NY - Search Results

1

Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.

Neymotin A, Petri S, Calingasan NY, Wille E, Schafer P, Stewart C, Hensley K, Beal MF, Kiaei M. Neymotin A, et al. Among authors: calingasan ny. Exp Neurol. 2009 Nov;220(1):191-7. doi: 10.1016/j.expneurol.2009.08.028. Epub 2009 Sep 4. Exp Neurol. 2009. PMID: 19733563 Free PMC article.

2

Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis.

Wu AS, Kiaei M, Aguirre N, Crow JP, Calingasan NY, Browne SE, Beal MF. Wu AS, et al. Among authors: calingasan ny. J Neurochem. 2003 Apr;85(1):142-50. doi: 10.1046/j.1471-4159.2003.01639.x. J Neurochem. 2003. PMID: 12641736 Free article.

3

Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.

Klivenyi P, Kiaei M, Gardian G, Calingasan NY, Beal MF. Klivenyi P, et al. Among authors: calingasan ny. J Neurochem. 2004 Feb;88(3):576-82. doi: 10.1046/j.1471-4159.2003.02160.x. J Neurochem. 2004. PMID: 14720207 Free article.

4

Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.

Kiaei M, Kipiani K, Chen J, Calingasan NY, Beal MF. Kiaei M, et al. Among authors: calingasan ny. Exp Neurol. 2005 Feb;191(2):331-6. doi: 10.1016/j.expneurol.2004.10.007. Exp Neurol. 2005. PMID: 15649489

5

Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis.

Kiaei M, Kipiani K, Petri S, Choi DK, Chen J, Calingasan NY, Beal MF. Kiaei M, et al. Among authors: calingasan ny. J Neurochem. 2005 Apr;93(2):403-11. doi: 10.1111/j.1471-4159.2005.03024.x. J Neurochem. 2005. PMID: 15816863 Free article.

6

Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.

Calingasan NY, Chen J, Kiaei M, Beal MF. Calingasan NY, et al. Neurobiol Dis. 2005 Jun-Jul;19(1-2):340-7. doi: 10.1016/j.nbd.2005.01.012. Neurobiol Dis. 2005. PMID: 15837590

7

Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis.

Petri S, Kiaei M, Kipiani K, Chen J, Calingasan NY, Crow JP, Beal MF. Petri S, et al. Among authors: calingasan ny. Neurobiol Dis. 2006 Apr;22(1):40-9. doi: 10.1016/j.nbd.2005.09.013. Epub 2005 Nov 11. Neurobiol Dis. 2006. PMID: 16289867

8

Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.

Kiaei M, Petri S, Kipiani K, Gardian G, Choi DK, Chen J, Calingasan NY, Schafer P, Muller GW, Stewart C, Hensley K, Beal MF. Kiaei M, et al. Among authors: calingasan ny. J Neurosci. 2006 Mar 1;26(9):2467-73. doi: 10.1523/JNEUROSCI.5253-05.2006. J Neurosci. 2006. PMID: 16510725 Free PMC article.

9

Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis.

Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, Beal MF. Petri S, et al. Among authors: calingasan ny. J Neurochem. 2006 Aug;98(4):1141-8. doi: 10.1111/j.1471-4159.2006.04018.x. J Neurochem. 2006. PMID: 16895581 Free article.

10

Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis.

Kiaei M, Kipiani K, Petri S, Chen J, Calingasan NY, Beal MF. Kiaei M, et al. Among authors: calingasan ny. Neurodegener Dis. 2005;2(5):246-54. doi: 10.1159/000090364. Neurodegener Dis. 2005. PMID: 16909005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters